120 related articles for article (PubMed ID: 23888343)
21. Epigenetic progression of columnar cell lesions of the breast to invasive breast cancer.
Verschuur-Maes AH; de Bruin PC; van Diest PJ
Breast Cancer Res Treat; 2012 Dec; 136(3):705-15. PubMed ID: 23104224
[TBL] [Abstract][Full Text] [Related]
22. Rapid determination of AKAP12 promoter methylation levels in peripheral blood using methylation-sensitive high resolution melting (MS-HRM) analysis: application in colorectal cancer.
Liu W; Guan M; Su B; Li J; Ma W; Liu C; Li M; Lin Y; Lu Y
Clin Chim Acta; 2010 Jul; 411(13-14):940-6. PubMed ID: 20227403
[TBL] [Abstract][Full Text] [Related]
23. Droplet Array Platform for High-Resolution Melt Analysis of DNA Methylation Density.
Athamanolap P; Shin DJ; Wang TH
J Lab Autom; 2014 Jun; 19(3):304-12. PubMed ID: 24114798
[TBL] [Abstract][Full Text] [Related]
24. Prognostic value of RASSF1 promoter methylation in prostate cancer.
Daniunaite K; Jarmalaite S; Kalinauskaite N; Petroska D; Laurinavicius A; Lazutka JR; Jankevicius F
J Urol; 2014 Dec; 192(6):1849-55. PubMed ID: 24980613
[TBL] [Abstract][Full Text] [Related]
25. A closed-tube methylation-sensitive high resolution melting assay (MS-HRMA) for the semi-quantitative determination of CST6 promoter methylation in clinical samples.
Dimitrakopoulos L; Vorkas PA; Georgoulias V; Lianidou ES
BMC Cancer; 2012 Oct; 12():486. PubMed ID: 23088560
[TBL] [Abstract][Full Text] [Related]
26. A one-step prescreening for point mutations and large rearrangement in BRCA1 and BRCA2 genes using quantitative polymerase chain reaction and high-resolution melting curve analysis.
Coulet F; Pires F; Rouleau E; Lefol C; Martin S; Colas C; Cohen-Haguenauer O; Giurgea I; Fajac A; Noguès C; Demange L; Hardouin A; Lidereau R; Soubrier F
Genet Test Mol Biomarkers; 2010 Oct; 14(5):677-90. PubMed ID: 20858050
[TBL] [Abstract][Full Text] [Related]
27. Prognosis of glioblastoma with faint MGMT methylation-specific PCR product.
Hsu CY; Ho HL; Lin SC; Chang-Chien YC; Chen MH; Hsu SP; Yen YS; Guo WY; Ho DM
J Neurooncol; 2015 Mar; 122(1):179-88. PubMed ID: 25575938
[TBL] [Abstract][Full Text] [Related]
28. Impact of hyperhomocysteinemia on breast cancer initiation and progression: epigenetic perspective.
Naushad SM; Reddy CA; Kumaraswami K; Divyya S; Kotamraju S; Gottumukkala SR; Digumarti RR; Kutala VK
Cell Biochem Biophys; 2014 Mar; 68(2):397-406. PubMed ID: 23934182
[TBL] [Abstract][Full Text] [Related]
29. Limitations and advantages of MS-HRM and bisulfite sequencing for single locus methylation studies.
Wojdacz TK; Møller TH; Thestrup BB; Kristensen LS; Hansen LL
Expert Rev Mol Diagn; 2010 Jul; 10(5):575-80. PubMed ID: 20629507
[TBL] [Abstract][Full Text] [Related]
30. Methylation profiles in breast cancer.
Buyru N; Altinisik J; Ozdemir F; Demokan S; Dalay N
Cancer Invest; 2009 Mar; 27(3):307-12. PubMed ID: 19194828
[TBL] [Abstract][Full Text] [Related]
31. Evaluation of promoter hypermethylation detection in serum as a diagnostic tool for breast carcinoma in Korean women.
Kim JH; Shin MH; Kweon SS; Park MH; Yoon JH; Lee JS; Choi C; Fackler MJ; Sukumar S
Gynecol Oncol; 2010 Aug; 118(2):176-81. PubMed ID: 20466412
[TBL] [Abstract][Full Text] [Related]
32. High-resolution melting analysis of BLU methylation levels in gastric, colorectal, and pancreatic cancers.
Shao Y; Zhang W; Zhang C; Wu Q; Yang H; Zhang J; Guan M; Wan J; Yu B
Cancer Invest; 2010 Jul; 28(6):642-8. PubMed ID: 20394502
[TBL] [Abstract][Full Text] [Related]
33. Methylated DNA and total DNA in serum detected by one-step methylation-specific PCR is predictive of poor prognosis for breast cancer patients.
Fujita N; Nakayama T; Yamamoto N; Kim SJ; Shimazu K; Shimomura A; Maruyama N; Morimoto K; Tamaki Y; Noguchi S
Oncology; 2012; 83(5):273-82. PubMed ID: 22964822
[TBL] [Abstract][Full Text] [Related]
34. Quantitative methylation-specific polymerase chain reaction gene patterns in urine sediment distinguish prostate cancer patients from control subjects.
Hoque MO; Topaloglu O; Begum S; Henrique R; Rosenbaum E; Van Criekinge W; Westra WH; Sidransky D
J Clin Oncol; 2005 Sep; 23(27):6569-75. PubMed ID: 16170165
[TBL] [Abstract][Full Text] [Related]
35. RASSF1A and CDH1 hypermethylation as potential epimarkers in breast cancer.
Sebova K; Zmetakova I; Bella V; Kajo K; Stankovicova I; Kajabova V; Krivulcik T; Lasabova Z; Tomka M; Galbavy S; Fridrichova I
Cancer Biomark; 2011-2012; 10(1):13-26. PubMed ID: 22297548
[TBL] [Abstract][Full Text] [Related]
36. High-resolution melting analyses for gene scanning of APC, MLH1, MSH2, and MSH6 associated with hereditary colorectal cancer.
Obul J; Itoga S; Abliz M; Sato K; Ishige T; Utsuno E; Matsushita K; Matsubara H; Nomura F
Genet Test Mol Biomarkers; 2012 May; 16(5):406-11. PubMed ID: 22283331
[TBL] [Abstract][Full Text] [Related]
37. Aberrant methylation of the Adenomatous Polyposis Coli (APC) gene promoter is associated with the inflammatory breast cancer phenotype.
Van der Auwera I; Van Laere SJ; Van den Bosch SM; Van den Eynden GG; Trinh BX; van Dam PA; Colpaert CG; van Engeland M; Van Marck EA; Vermeulen PB; Dirix LY
Br J Cancer; 2008 Nov; 99(10):1735-42. PubMed ID: 18841156
[TBL] [Abstract][Full Text] [Related]
38. High-resolution melting analysis of HPV-16L1 gene methylation: A promising method for prognosing cervical cancer.
Qiu C; Zhi Y; Shen Y; Gong J; Li Y; Li X
Clin Biochem; 2015 Sep; 48(13-14):855-9. PubMed ID: 25982893
[TBL] [Abstract][Full Text] [Related]
39. Increased promoter methylation in exfoliated breast epithelial cells in women with a previous breast biopsy.
Browne EP; Punska EC; Lenington S; Otis CN; Anderton DL; Arcaro KF
Epigenetics; 2011 Dec; 6(12):1425-35. PubMed ID: 22139572
[TBL] [Abstract][Full Text] [Related]
40. Accurate monitoring of promoter gene methylation with high-resolution melting polymerase chain reaction using the ABCB1 gene as a model.
Mencalha AL; Rodrigues EF; Abdelhay E; Fernandez TS
Genet Mol Res; 2013 Mar; 12(1):714-22. PubMed ID: 23546954
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]